Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
- DOI
- 10.1186/s12885-023-11539-1
- Published
- 2023-11-03
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-023-11539-1,
title = {Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study},
author = {Do-Youn Oh and Maria Alsina Maqueda and David I. Quinn and Peter J. O’Dwyer and Ian Chau and Sun Young Kim and Ignacio Duran and Daniel Castellano and Jordan Berlin and Begona Mellado and Stephen K. Williamson and Keun-Wook Lee and Francisca Marti and Paul Mathew and Muhammad Wasif Saif and Ding Wang and Elizabeth Chong and Jacqueline Hilger-Rolfe and James P. Dean and Hendrik-Tobias Arkenau},
year = {2023},
journal = {BMC Cancer},
doi = {10.1186/s12885-023-11539-1},
url = {https://doi.org/10.1186/s12885-023-11539-1}
}RIS
TY - JOUR TI - Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study AU - Do-Youn Oh AU - Maria Alsina Maqueda AU - David I. Quinn AU - Peter J. O’Dwyer AU - Ian Chau AU - Sun Young Kim AU - Ignacio Duran AU - Daniel Castellano AU - Jordan Berlin AU - Begona Mellado AU - Stephen K. Williamson AU - Keun-Wook Lee AU - Francisca Marti AU - Paul Mathew AU - Muhammad Wasif Saif AU - Ding Wang AU - Elizabeth Chong AU - Jacqueline Hilger-Rolfe AU - James P. Dean AU - Hendrik-Tobias Arkenau PY - 2023 JO - BMC Cancer DO - 10.1186/s12885-023-11539-1 UR - https://doi.org/10.1186/s12885-023-11539-1 ER -
APA
Oh, D., Maqueda, M. A., Quinn, D. I., O’Dwyer, P. J., Chau, I., Kim, S. Y., Duran, I., Castellano, D., Berlin, J., Mellado, B., Williamson, S. K., Lee, K., Marti, F., Mathew, P., Saif, M. W., Wang, D., Chong, E., Hilger-Rolfe, J., Dean, J. P., & Arkenau, H. (2023). Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study. BMC Cancer. https://doi.org/10.1186/s12885-023-11539-1
Source records
- crossref · retrieved 2026-09-26T09:46:57.058Z